ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹753 Cr | ₹801 Cr | ₹656 Cr | ₹657 Cr | ₹674 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹753 Cr |
Mar2023 | ₹801 Cr |
Mar2022 | ₹656 Cr |
Mar2021 | ₹657 Cr |
Mar2020 | ₹674 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹753 Cr | -5.98 | |
Mar2023 | ₹801 Cr | 22.19 | |
Mar2022 | ₹656 Cr | -0.24 | |
Mar2021 | ₹657 Cr | -2.46 | |
Mar2020 | ₹674 Cr | - |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹89,229.8 Cr | -0.1% | -0.5% | -10.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,406.0 Cr | -2.7% | 3.9% | 19.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,113.0 Cr | 1% | 8.5% | 55.3% | Stock Analytics | |
CIPLA | ₹121,869.0 Cr | -2.6% | 3.9% | 6.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,345.0 Cr | -0.7% | 2.5% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,801.0 Cr | -1.9% | 0.9% | -7.8% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -0.1% |
-0.5% |
-10.9% |
SENSEX | 0.6% |
6.2% |
8.4% |
You may also like the below Video Courses